15 research outputs found

    Image_6.TIF

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Image_5.TIF

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Table_1.xlsx

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Image_2.TIF

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Image_1.TIF

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Image_3.TIF

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Data_Sheet_1.pdf

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Image_4.TIF

    No full text
    <p>Background: Cochlear and vestibular epithelial non-hair cells (ENHCs) are the supporting elements of the cellular architecture in the organ of Corti and the vestibular neuroepithelium in the inner ear. Intercellular and cell-extracellular matrix interactions are essential to prevent an abnormal ion redistribution leading to hearing and vestibular loss. The aim of this study is to define the main pathways and molecular networks in the mouse ENHCs.</p><p>Methods: We retrieved microarray and RNA-seq datasets from mouse epithelial sensory and non-sensory cells from gEAR portal (http://umgear.org/index.html) and obtained gene expression fold-change between ENHCs and non-epithelial cells (NECs) against HCs for each gene. Differentially expressed genes (DEG) with a log2 fold change between 1 and −1 were discarded. The remaining genes were selected to search for interactions using Ingenuity Pathway Analysis and STRING platform. Specific molecular networks for ENHCs in the cochlea and the vestibular organs were generated and significant pathways were identified.</p><p>Results: Between 1723 and 1559 DEG were found in the mouse cochlear and vestibular tissues, respectively. Six main pathways showed enrichment in the supporting cells in both tissues: (1) “Inhibition of Matrix Metalloproteases”; (2) “Calcium Transport I”; (3) “Calcium Signaling”; (4) “Leukocyte Extravasation Signaling”; (5) “Signaling by Rho Family GTPases”; and (6) “Axonal Guidance Si”. In the mouse cochlea, ENHCs showed a significant enrichment in 18 pathways highlighting “axonal guidance signaling (AGS)” (p = 4.37 × 10<sup>−8</sup>) and “RhoGDI Signaling” (p = 3.31 × 10<sup>−8</sup>). In the vestibular dataset, there were 20 enriched pathways in ENHCs, the most significant being “Leukocyte Extravasation Signaling” (p = 8.71 × 10<sup>−6</sup>), “Signaling by Rho Family GTPases” (p = 1.20 × 10<sup>−5</sup>) and “Calcium Signaling” (p = 1.20 × 10<sup>−5</sup>). Among the top ranked networks, the most biologically significant network contained the “auditory and vestibular system development and function” terms. We also found 108 genes showing tonotopic gene expression in the cochlear ENHCs.</p><p>Conclusions: We have predicted the main pathways and molecular networks for ENHCs in the organ of Corti and vestibular neuroepithelium. These pathways will facilitate the design of molecular maps to select novel candidate genes for hearing or vestibular loss to conduct functional studies.</p

    Image_1.pdf

    No full text
    <p>Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a rare disorder with an unknown etiology. We present a British family with presumed autosomal dominant CANVAS with incomplete penetrance and variable expressivity. Exome sequencing identified a rare missense variant in the ELF2 gene at chr4:g.140058846 C > T, c.10G > A, p.A4T which segregated in all affected patients. By using transduced BE (2)-M17 cells, we found that the mutated ELF2 (mt-ELF2) gene increased ATXN2 and reduced ELOVL5 gene expression, the causal genes of type 2 and type 38 spinocerebellar ataxias. Both, western blot and confocal microscopy confirmed an increase of ataxin-2 in BE(2)-M17 cells transduced with lentivirus expressing mt-ELF2 (CEE-mt-ELF2), which was not observed in cells transduced with lentivirus expressing wt-ELF2 (CEE-wt-ELF2). Moreover, we observed a significant decrease in the number and size of lipid droplets in the CEE-mt-ELF2-transduced BE (2)-M17 cells, but not in the CEE-wt-ELF2-transduced BE (2)-M17. Furthermore, changes in the expression of ELOVL5 could be related with the reduction of lipid droplets in BE (2)-M17 cells. This work supports that ELF2 gene regulates the expression of ATXN2 and ELOVL5 genes, and defines new molecular links in the pathophysiology of cerebellar ataxias.</p

    Table_1.pdf

    No full text
    <p>Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a rare disorder with an unknown etiology. We present a British family with presumed autosomal dominant CANVAS with incomplete penetrance and variable expressivity. Exome sequencing identified a rare missense variant in the ELF2 gene at chr4:g.140058846 C > T, c.10G > A, p.A4T which segregated in all affected patients. By using transduced BE (2)-M17 cells, we found that the mutated ELF2 (mt-ELF2) gene increased ATXN2 and reduced ELOVL5 gene expression, the causal genes of type 2 and type 38 spinocerebellar ataxias. Both, western blot and confocal microscopy confirmed an increase of ataxin-2 in BE(2)-M17 cells transduced with lentivirus expressing mt-ELF2 (CEE-mt-ELF2), which was not observed in cells transduced with lentivirus expressing wt-ELF2 (CEE-wt-ELF2). Moreover, we observed a significant decrease in the number and size of lipid droplets in the CEE-mt-ELF2-transduced BE (2)-M17 cells, but not in the CEE-wt-ELF2-transduced BE (2)-M17. Furthermore, changes in the expression of ELOVL5 could be related with the reduction of lipid droplets in BE (2)-M17 cells. This work supports that ELF2 gene regulates the expression of ATXN2 and ELOVL5 genes, and defines new molecular links in the pathophysiology of cerebellar ataxias.</p
    corecore